The pregnant women who will now be included in phase 3 and therefore may soon receive their first vaccine are those who are overweight, those who are over 35 years old and pregnant women who have certain diseases.
The rest will have to wait.
Today's message is important, because so far no pregnant woman has been vaccinated in Sweden.
Even if you belonged to a risk group and therefore should have been placed in the phase where the vaccination took place, all pregnant women have been sorted out.
Not even pregnant women who have received a certificate from a doctor that they should be vaccinated have been able to book in to get a syringe.
Now it will be the other way around.
Obvious risks
It has long been known that there are clear and fairly large risks for a pregnant woman who is infected with the coronavirus.
Chief physician Karin Pettersson, told me today on the phone that she and several others pointed out the risk of pregnant women becoming seriously ill with corona as early as April last year.
In addition, the risk of the baby being born prematurely also increases.
During the past year, contacts with the authority have continued on this issue.
And today the message finally came.
Although to some extent there is still a lack of extensive studies on vaccines for pregnant women, the authority believes that the reports on the risks of the disease itself for pregnant women still prevail.
A wise decision, but at the same time a decision that can lead to more and new demands also from other groups, for example from other pregnant women who are not covered.
Information challenge
A group of very angry pregnant doctors today cannot accept that they too cannot be allowed to lead the vaccination queue.
And all middle-aged men could make the same demands because they are four times more likely than others to die of corona.
And why do not obese people get vaccinated immediately, even though study after study states that obesity is a major risk factor?
The list of those who think they should get vaccinated as soon as possible can be made long.
The answer is probably again the question of risk versus benefit with the vaccine.
And one more thing, namely the information problems.
If a message is to get through, it must be simple and clear.
And preferably not changed.
The authority has bitterly experienced this with regard to Astra Zeneca's vaccine.
All in all, it can still be stated that the question of vaccines, who should or should not have vaccines, and which vaccine they should receive, has turned out to be incredibly charged - from beginning to end.